Recent Media Coverage
Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.
Like many chemists of a certain age, Derek Lowe remembers the exact moment when he learned about the chemical-structure-drawing program we now call ChemDraw.
Technologies such as PerkinElmer’s Opal platform and its multispectral imaging and analysis software allow researchers to multiplex immunology markers in a single assay on a single slide.
In a research first, Tufts scientists have witnessed atoms of one chemical element morph into another.
PerkinElmer, a maker of high-tech equipment used in the pharmaceutical industry, is joining Albany Molecular Research Inc. in a new, multimillion-dollar drug development hub soon to open on the Buffalo Niagara Medical Campus.
To minimize complexity, researchers often study cellular proteins or nucleic acids in isolation.